MedTrace Logo

Medicines Reconciliation at an Intensive Care Unit

NCT03173690 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-07-11

No results posted yet for this study

Summary

This study evaluates the effect of performing medicines reconciliation on patients admitted to an intensive care unit. Half of the patients will receive a medicines reconciliation at the intensive care unit. The other half will not. All included patients will receive medicines reconciliation after transfer to the ward.

Conditions

  • Medicines Reconciliation
  • Intensive Care Unit

Interventions

OTHER

Medication reconciliation at the ICU

Medication reconciliation performed according to Integrated Medicines Management model

OTHER

Medication Reconciliation at the Ward

Medication reconciliation performed according to Integrated Medicines Management model

Sponsors & Collaborators

  • Hospital Pharmacy Enterprise, South Eastern Norway

    collaborator OTHER

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Silje E Oernes, PhD · Hospital Pharmacy Enterprise, South Eastern Norway

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-06
Primary Completion
2017-07-06
Completion
2017-10-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173690 on ClinicalTrials.gov